Skip to main content
    S

    Sonoma Pharmaceuticals Inc (SNOA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.88
    -0.21 (-19.25%)

    Market Cap: $5.52M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Sonoma Pharmaceuticals Inc (SNOA) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Sonoma Pharmaceuticals (SNOA) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Sonoma Pharmaceuticals reported EPS of $0.09. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(15/27)
    Avg Surprise
    +8.04%

    Next Report

    SNOA has an expected report date of Feb 8, 2027.

    Earnings History

    Of the 28 quarters below that had an estimate, SNOA beat 16, missed 11 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $7.17M, up 28.0% from $5.60M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.09N/AN/AN/AN/AN/AN/AN/ANov 10, 2026$7.17M
    Jun 30, 2026$0.02N/AN/AN/AN/AN/AN/AN/AAug 6, 2026$6.41M
    Mar 31, 2026-$0.15N/AN/AN/AN/AN/AN/AN/AJun 16, 2026$5.56M
    Dec 31, 2025-$0.48-$0.29-$0.29 - -$0.29-65.52%MissN/A10 up, 0 downFeb 10, 2026$4.35M
    Sep 30, 2025-$0.32-$0.31-$0.31 - -$0.31-3.23%MissN/A11 up, 0 downNov 4, 2025$5.60M
    Jun 30, 2025-$0.37-$0.51N/A+27.45%BeatN/AN/A0 up, 0 downAug 7, 2025$4.01M
    Mar 31, 2025-$0.48-$0.04N/AN/AN/AN/AN/A0 up, 0 downJun 17, 2025$3.75M
    Dec 31, 2024-$0.63-$0.60-$0.60 - -$0.60-5.00%MissN/A10 up, 0 downFeb 5, 2025$3.56M
    Sep 30, 2024-$0.59-$0.80N/A+26.25%BeatN/A10 up, 0 downNov 7, 2024$3.58M
    Jun 30, 2024-$1.40-$0.80N/A-75.00%MissN/A10 up, 0 downAug 8, 2024$3.39M
    Mar 31, 2024-$0.07-$0.17N/A+58.82%BeatN/AN/A0 up, 0 downJun 17, 2024$3.44M
    Dec 31, 2023-$1.60-$4.20-$4.20 - -$4.20+61.90%BeatN/A10 up, 0 downFeb 8, 2024$3.14M
    Sep 30, 2023-$5.80-$4.80-$4.80 - -$4.80-20.83%MissN/A10 up, 0 downNov 13, 2023$2.73M
    Jun 30, 2023-$0.28-$0.12N/A-133.00%MissN/AN/A0 up, 0 downAug 10, 2023$3.43M
    Mar 31, 2023-$0.31-$0.23N/A-34.78%MissN/AN/A0 up, 0 downJun 21, 2023$3.01M
    Dec 31, 2022-$0.62-$0.62N/A0.00%In lineN/AN/A0 up, 0 downFeb 14, 2023$2.94M
    Sep 30, 2022-$0.33N/AN/AN/AN/AN/AN/A0 up, 0 downNov 14, 2022$3.33M
    Jun 30, 2022-$0.29N/AN/AN/AN/AN/AN/A0 up, 0 downJul 13, 2022$3.98M
    Dec 31, 2021-$0.31N/AN/AN/AN/AN/AN/A0 up, 0 downFeb 11, 2022$2.90M
    Sep 30, 2021-$0.04N/AN/AN/AN/A-166.7%N/AN/ANov 15, 2021$3.74M
    Jun 30, 2021-$0.52N/AN/AN/AN/A-196.3%N/A0 up, 0 downJul 14, 2021$3.68M
    Mar 31, 2021-$0.52N/AN/AN/AN/AN/AN/A0 up, 0 downJun 30, 2021$2.16M
    Dec 31, 2020-$0.32-$0.72N/A+55.56%Beat-102.5%N/AN/AFeb 16, 2021$4.94M
    Sep 30, 2020$0.06-$1.18N/A+105.08%BeatN/AN/AN/ANov 20, 2020$5.77M
    Jun 30, 2020$0.54-$0.91N/A+159.34%BeatN/AN/AN/AJul 10, 2020$5.77M
    Mar 31, 2020-$0.39N/AN/AN/AN/AN/AN/AN/AJun 30, 2020$4.42M
    Dec 31, 2019$12.72-$0.72N/AN/AN/AN/AN/AN/AFeb 14, 2020$4.39M
    Sep 30, 2019-$18.20-$23.60-$23.60 - -$23.60+22.88%BeatN/A1N/ANov 14, 2019$4.73M
    Jun 30, 2019-$26.70-$35.80-$35.80 - -$35.80+25.42%BeatN/A1N/AJul 8, 2019$4.38M
    Mar 31, 2019-$1.52-$2.12-$2.45 - -$1.80+28.30%BeatN/A2N/AJun 30, 2019$9.58M
    Dec 31, 2018-$46.80-$60.30-$82.81 - -$37.80+22.39%BeatN/A2N/AFeb 14, 2019$10.32M
    Sep 30, 2018-$79.20-$81.90-$99.01 - -$64.81+3.30%BeatN/A2N/ANov 8, 2018$9.57M
    Jun 30, 2018-$99.00-$95.40-$95.41 - -$70.21-3.77%MissN/A2N/AAug 8, 2018$8.46M
    Mar 31, 2018-$8.37-$5.28-$5.94 - -$4.05-58.52%MissN/A3N/AJun 13, 2018$3.65M
    Dec 31, 2017-$131.40-$111.00-$113.41 - -$108.01-18.38%Miss-117.8%3N/AFeb 7, 2018$4.84M
    Sep 30, 2017-$120.60-$124.20N/A+2.90%BeatN/AN/AN/ANov 9, 2017$4.33M
    Jun 30, 2017-$147.60-$131.40N/A-12.33%MissN/AN/AN/AAug 8, 2017$3.83M
    Mar 31, 2017-$5.13-$6.03N/A+14.93%BeatN/AN/AN/AJun 5, 2017$4.03M
    Dec 31, 2016$736.56$554.40N/A+32.86%BeatN/AN/AN/AFeb 9, 2017$3.36M
    Sep 30, 2016-$63.72-$106.20N/A+40.00%BeatN/AN/AN/ANov 10, 2016$2.80M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Mar 31, 2026 was -$1.32, after -$3.10 the year before. It was -$313.63 for the year ended Mar 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Mar 31, 2026-$1.32N/A
    Mar 31, 2025-$3.10N/A
    Mar 31, 2024-$7.75N/A
    Mar 31, 2023-$2.42N/A
    Mar 31, 2021-$0.24N/A
    Mar 31, 2020-$32.57N/A
    Mar 31, 2019-$226.52N/A
    Mar 31, 2018-$407.97-170.9%
    Mar 31, 2017$575.19N/A
    Mar 31, 2016-$313.63N/A

    Frequently Asked Questions About SNOA

    When is Sonoma Pharmaceuticals's next earnings date?

    Sonoma Pharmaceuticals's next earnings report is expected for Feb 8, 2027.

    How often does SNOA beat earnings estimates?

    Sonoma Pharmaceuticals beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +3.21%.